Development of an Algorithm to Predict Mortality in Patients With Sepsis and Coagulopathy.


Journal

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
ISSN: 1938-2723
Titre abrégé: Clin Appl Thromb Hemost
Pays: United States
ID NLM: 9508125

Informations de publication

Date de publication:
Historique:
entrez: 5 3 2020
pubmed: 5 3 2020
medline: 22 10 2020
Statut: ppublish

Résumé

Sepsis is a systemic response to infection with a high rate of mortality and complex pathophysiology involving inflammation, infection response, hemostasis, endothelium, and platelets. The purpose of this study was to develop an equation incorporating biomarker levels at intensive care unit (ICU) admission to predict mortality in patients with sepsis, based on the hypothesis that a combination of biomarkers representative of multiple physiological systems would provide improved predictive value. Plasma samples and clinical data were collected from 103 adult patients with sepsis at the time of ICU admission. Biomarker levels were measured using commercially available methods. A 28-day mortality was used as the primary end point. Stepwise linear regression modeling was performed to generate a predictive equation for mortality. Differences in biomarker levels between survivors were quantified using the Mann-Whitney test and the area under the receiver operating curve (AUC) was used to describe predictive ability. Significant differences (

Identifiants

pubmed: 32129085
doi: 10.1177/1076029620902849
pmc: PMC7288806
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1076029620902849

Subventions

Organisme : NIA NIH HHS
ID : R01 AG048022
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL126547
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL130541
Pays : United States
Organisme : NHLBI NIH HHS
ID : U54 HL112311
Pays : United States

Références

Inflamm Res. 2004 Apr;53(4):158-63
pubmed: 15060722
J Gerontol A Biol Sci Med Sci. 2015 Feb;70(2):225-31
pubmed: 24917177
Crit Care. 2007;11(2):R49
pubmed: 17448250
Crit Care Med. 2005 Nov;33(11):2540-6
pubmed: 16276178
Shock. 2005 Jun;23(6):488-93
pubmed: 15897799
J Inflamm (Lond). 2013 Mar 06;10(1):8
pubmed: 23510603
Crit Care Med. 2004 Dec;32(12):2416-21
pubmed: 15599145
J Immunol. 2006 Aug 1;177(3):1967-74
pubmed: 16849510
Crit Care Med. 2005 Feb;33(2):341-8
pubmed: 15699837
Expert Rev Anti Infect Ther. 2012 Jun;10(6):701-6
pubmed: 22734959
J Thromb Haemost. 2011 Apr;9(4):748-58
pubmed: 21255247
Am J Respir Crit Care Med. 2016 Feb 1;193(3):259-72
pubmed: 26414292
Chest. 2012 Jun;141(6):1490-1495
pubmed: 22383669
J Infect Dis. 2000 Jan;181(1):176-80
pubmed: 10608764
J Infect Chemother. 2014 Mar;20(3):157-62
pubmed: 24530102
N Engl J Med. 2005 Sep 29;353(13):1332-41
pubmed: 16192478
Cytokine. 2012 Mar;57(3):332-6
pubmed: 22197776
Natl Vital Stat Rep. 2013 May 8;61(4):1-117
pubmed: 24979972
Crit Care. 2010;14(3):R89
pubmed: 20482750
J Thromb Haemost. 2015 Oct;13(10):1743-56
pubmed: 26190521
Crit Care. 2004 Apr;8(2):R82-90
pubmed: 15025782
Thromb Res. 2015 Sep;136(3):542-7
pubmed: 26232351
Cytokine. 2006 Dec;36(5-6):283-90
pubmed: 17368039
Intensive Care Med. 2010 Apr;36(4):621-9
pubmed: 20119647
NCHS Data Brief. 2013 Mar;(118):1-8
pubmed: 23742820
J Crit Care. 2017 Apr;38:57-61
pubmed: 27863269
Crit Care Med. 2015 Oct;43(10):2094-103
pubmed: 26121070
MMWR Morb Mortal Wkly Rep. 2016 Apr 08;65(13):342-5
pubmed: 27054476
Crit Care Med. 2003 Mar;31(3):670-5
pubmed: 12626967
Crit Care Med. 2011 Apr;39(4):702-10
pubmed: 21242795
Sci Transl Med. 2013 Jul 24;5(195):195ra95
pubmed: 23884467
Crit Care Med. 2009 May;37(5):1649-54
pubmed: 19325482
Crit Care Med. 2013 May;41(5):1167-74
pubmed: 23442987
Int J Infect Dis. 2006 Jan;10(1):25-31
pubmed: 16290015
J Crit Care. 2016 Feb;31(1):58-62
pubmed: 26601855
Blood. 2014 Feb 13;123(7):1098-101
pubmed: 24264231
JAMA. 2003 Jul 9;290(2):238-47
pubmed: 12851279
Blood. 2016 Jun 16;127(24):3062-72
pubmed: 26956172
Crit Care Med. 2005 Mar;33(3):564-73
pubmed: 15753748
Crit Care Med. 2016 Nov;44(11):2018-2027
pubmed: 27441903
JAMA. 2017 Jan 17;317(3):301-308
pubmed: 28114554
N Engl J Med. 1999 Aug 19;341(8):586-92
pubmed: 10451465
Shock. 2009 Apr;31(4):348-53
pubmed: 18791490
Am J Transplant. 2016 Jan;16(1):204-12
pubmed: 26375609
Crit Care Med. 2006 Feb;34(2):532-7
pubmed: 16424738
Injury. 2018 Jun;49(6):1141-1148
pubmed: 29580646
Crit Care Med. 2016 Oct;44(10):e930-9
pubmed: 27322364
Crit Care. 2010;14(2):R44
pubmed: 20331902
Anaesth Intensive Care. 2016 Jan;44(1):57-64
pubmed: 26673590

Auteurs

Amanda Walborn (A)

Departments of Pathology, Loyola University Medical Center, Maywood, IL, USA.
Departments of Pharmacology, Loyola University Medical Center, Maywood, IL, USA.

Matthew Rondina (M)

Department of Internal Medicine and the Molecular Medicine Program, University of Utah and the GRECC, George E. Wahlen VAMC, Salt Lake City, UT, USA.

Jawed Fareed (J)

Departments of Pathology, Loyola University Medical Center, Maywood, IL, USA.
Departments of Pharmacology, Loyola University Medical Center, Maywood, IL, USA.

Debra Hoppensteadt (D)

Departments of Pathology, Loyola University Medical Center, Maywood, IL, USA.
Departments of Pharmacology, Loyola University Medical Center, Maywood, IL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH